On January 24, 2022, Hemanext announced that its innovative blood processing and storage system has been recognized by the Association for the Advancement of Blood & Biotherapies (“AABB”), a leading international association in transfusion medicine and biotherapies, for compliance with its industry-recognized quality and safety standards SCoPE Program. The Hemanext technology is the first system providing both blood processing and storage to receive this designation.
Recent Posts
- Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community
- Hemanext Announces Close of Series B Equity Funding Round
- European Patients Have Begun Receiving Transfusions with Hemanext ONE® RBC Processing and Storage System
- Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances
- Hemanext Launches European Sales of Hemanext ONE® System in Italy and the Nordics